Back

Spatial Neuroimmune Crosstalk Driving Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Chhabra, R.; Kao, A.; Ding, R.; Bajaj, S.; Jackson, S. G.; Li, W. T.; John, D. J.; Wang-Rodriguez, J.; Ongkeko, W. M.

2026-05-29 cancer biology
10.64898/2026.05.26.727931 bioRxiv
Show abstract

BackgroundPerineural invasion (PNI) is a clinically important feature of aggressive head and neck squamous cell carcinoma (HNSCC) and is associated with recurrence and poor survival. However, the spatial organization and molecular programs that characterize tumor-nerve interactions in HNSCC remain incompletely understood. MethodsSingle-cell-resolution Xenium spatial transcriptomic data from 10 HNSCC patients were analyzed to define nerve-associated regions, cell-type composition, tumor-nerve proximity, and perineural transcriptional programs. Complementary Visium spatial transcriptomic datasets were used to assess broader transcriptomic features of nerve-associated regions, including epithelial-mesenchymal transition and inferred ligand-receptor signaling. Clinical relevance was evaluated using bulk transcriptomic validation cohorts from TCGA-HNSC and GSE65858. ResultsSpatial mapping identified a distinct nerve-proximal microenvironment characterized by depletion of mature dendritic cells and altered immune and stromal composition, consistent with localized disruption of antigen-presenting support at the tumor-nerve interface. HPV- tumors exhibited closer tumor-nerve proximity and a higher exploratory PNI index compared with HPV+ tumors, suggesting subtype-specific differences in nerve-associated tumor behavior. Differential expression analysis of perineural versus distal tumor cells identified a spatially enriched gene program, including NFE2L2, MDM2, and PPARG, that demonstrated a nerve-proximal gradient most evident in HPV- disease. A composite three-gene score was associated with worse overall survival in HPV- patients in TCGA-HNSC and validated in GSE65858, while showing limited prognostic value in HPV+ disease. Visium analyses provided complementary evidence of EMT enrichment and inferred tumor-nerve signaling involving neural guidance and adhesion-associated pathways. ConclusionsThese findings support a model in which PNI in HNSCC reflects a spatially organized, transcriptionally distinct tumor-nerve microenvironment, particularly in HPV- disease. The NFE2L2/MDM2/PPARG signature may provide a candidate biomarker for risk stratification and nominates pathways for future mechanistic and therapeutic investigation.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Clinical Cancer Research
58 papers in training set
Top 0.1%
8.5%
2
Neuro-Oncology
30 papers in training set
Top 0.2%
6.9%
3
International Journal of Cancer
42 papers in training set
Top 0.1%
6.9%
4
Nature Communications
4913 papers in training set
Top 28%
6.5%
5
PLOS ONE
4510 papers in training set
Top 30%
4.9%
6
Scientific Reports
3102 papers in training set
Top 22%
4.9%
7
Cancers
200 papers in training set
Top 2%
3.3%
8
Cancer Research Communications
46 papers in training set
Top 0.2%
2.9%
9
Frontiers in Oncology
95 papers in training set
Top 1%
2.6%
10
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.5%
2.4%
11
Molecular Oncology
50 papers in training set
Top 0.2%
2.1%
50% of probability mass above
12
British Journal of Cancer
42 papers in training set
Top 0.7%
1.9%
13
Acta Neuropathologica Communications
81 papers in training set
Top 0.5%
1.8%
14
The Journal of Pathology
22 papers in training set
Top 0.1%
1.8%
15
Journal of Translational Medicine
46 papers in training set
Top 0.9%
1.7%
16
Molecular Cancer
14 papers in training set
Top 0.3%
1.7%
17
JCI Insight
241 papers in training set
Top 3%
1.7%
18
Neuro-Oncology Advances
24 papers in training set
Top 0.3%
1.7%
19
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
20
OncoImmunology
22 papers in training set
Top 0.2%
1.5%
21
Annals of Oncology
13 papers in training set
Top 0.5%
1.5%
22
npj Precision Oncology
48 papers in training set
Top 0.7%
1.3%
23
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.4%
1.3%
24
Genome Medicine
154 papers in training set
Top 5%
1.3%
25
eBioMedicine
130 papers in training set
Top 2%
1.2%
26
Oncogene
76 papers in training set
Top 1%
1.2%
27
Cell Reports
1338 papers in training set
Top 30%
0.9%
28
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 41%
0.9%
29
Frontiers in Immunology
586 papers in training set
Top 6%
0.9%
30
Molecular Cancer Research
42 papers in training set
Top 0.6%
0.9%